Nanogami is pioneering the next-generation biochip for research, diagnostics, and personalized medicine. Their biochip platform offers ultra-high feature density, modularity, and adaptability to integrate and enhance sequencing, transcriptomics, and proteomics applications. To realize this vision, SPRIND - Germany's Federal Agency for Disruptive Innovation funds Nanogami as one of six projects for the next five years.
